Middle East and North Africa Allergy Diagnostics Market is expected to grow at a CAGR of 8.7% in the forecast period 2020 to 2027. The years considered for study are as mentioned below.
Middle East and North Africa allergy diagnostics market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased various strategic developments owing to favourable market scenario.
The major players dealing in Middle East and North Africa allergy diagnostics market are introducing strong range of product portfolio. This has also helped the company to maximize the sales with enhanced product portfolio. For instance, in August 2019, Omega Diagnostics Group PLC announced that they received CE marked approval on their allergens product. The CE marked approval authorised the company to commercialize their product in the market.
Omega Diagnostics Group PLC is the dominating player in the allergy diagnostics market. The other key players existing in the market includes Siemens HealthineersAG, R-Biopharm AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., Indoor Biotechnologies, Inc., bioMérieux SA, Quest Diagnostics Incorporated, ROXALL Medizin GmbH, Hitachi, Ltd. among others.
Omega Diagnostics Group PLC
Omega Diagnostics Group PLC, headquartered in Scotland, U.K., was established in 2006. The company has its product categories such as global health, food intolerance and allergy. In this, allergy is the market focused category.
The company has wide global presence across the globe such as UK, Germany and India. In addition to it, the company also generates its revenue from the various subsidiary companies such as Co-Tek (South-West) Ltd (U.K.), Genesis Diagnostics Ltd (U.S.), Omega Diagnostics GmbH (Germany) and Omega Dx (Asia) Pvt Ltd (India) and Cambridge Nutritional Sciences Ltd (U.K.).
Siemens Healthineers AG
Siemens Healthineers AG has headquartered in Erlangen, Germany. The products category offered by the company is medical imaging, laboratory diagnostics, point-of-care testing, services, healthcare IT, clinical specialties, accessories and OEM & electronics.
The company has wide global presence across the globe such as Europe, Asia-Pacific, North America, South America, Middle East and Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as Siemens Healthcare SAS (France), Dedicated2Imaging LLC, (United States), AcroradCo., Ltd., (Japan), Siemens Healthcare d.o.o., (Croatia) and Siemens Healthcare Nederland B.V. (Netherlands) among others.
R-Biopharm AG has headquartered in Darmstadt, Germany and it was founded in 1988. The company engages in the development of test solution for clinical diagnostics and food & feed analysis.
The company has presence in North America, South America, Asia-Pacific and Europe.
Recent Strategic Decisions